Desmond Yip

Has grant

Professor (Full)

Australian National University Medical School

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Desmond Yip is a full professor at the Australian National University Medical School in Australia. His research focuses on oncology, specifically topics such as chemotherapy and radiotherapy for pancreatic cancer, treatment strategies for gastrointestinal stromal tumors, and the use of circulating tumor DNA in cancer therapy. He has also contributed to studies evaluating patient outcomes in gallbladder cancer and venous thromboembolism among lung cancer patients.

Recent Grants

Grant: Close

Epigenetic regulation by PKC-theta in human breast cancer stem cells.

Open Date: 2016-01-01

Close Date: 2019-01-01

Grant: Close

Breast Cancer Biospecimen Resource

Open Date: 2010-01-01

Close Date: 2015-01-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (22)

Ian A. Cockburn

Australian National University

AUSTRALIA

Desmond Yip

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial

Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma—Retrospective Review From a Tertiary Care Hospital

Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial

External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer

Response to COVID-19 vaccination in patients on cancer therapy

Feasibility, acceptability, and preliminary efficacy of a self-directed online psychosocial intervention for women with metastatic breast cancer: Finding My Way-Advanced

Outcomes of patients with gallbladder cancer presenting with acute cholecystitis

Models for predicting venous thromboembolism in ambulatory patients with lung cancer

Chemotherapy and radiotherapy for advanced pancreatic cancer

Reply to D. Bush et al

Building Capability and Capacity: The Establishment of an Oncology Unit in the Solomon Islands

Clinical predictors of survival in real world practice in stage IV melanoma

PREOPANC Trial: Survival in the Control Arm and Role of Radiation Need More Explanation

A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED).

Prediction models for venous thromboembolism in ambulatory adults with pancreatic and gastro-oesophageal cancer: protocol for systematic review and meta-analysis.

Selective Targeting of Protein Kinase C (PKC)-&theta; Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8<sup>+</sup> T Cells in Immunotherapy-Resistant and Metastatic Cancers

The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours.

Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspective.

Models for predicting venous thromboembolism in ambulatory patients with lung cancer: a systematic review protocol.

Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice.

Collaborators (22)

Ian A. Cockburn

Emma Kemp

Joshua Cohen

Phil Newman

David Jans

Sivakumar Gananadha

Timothy J. Price

Serigne N. Lô

Geoffrey Peters

Belinda Lee

Mark Naunton

John R. Zalcberg

Reza Mortazavi

Kristine Hardy

Lorraine Chantrill

Nicholas James Hulbert-Williams

Teresa Neeman

Sudha Rao

Elizabeth Gardiner

Jean-Yves Blay

Nicholas Brown

Rachel Wong

Make your next move.

Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8<sup>+</sup> T Cells in Immunotherapy-Resistant and Metastatic Cancers